concatameric TFNR1Ig therapy program (Medexgen)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameconcatameric TFNR1Ig therapy program (Medexgen)

Drug Alias Nameconcatameric CD120aIg therapy program (Medexgen)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionTumor necrosis factor receptor superfamily member 1A modulators

TargetsTumor necrosis factor receptor superfamily member 1A

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMedexgen Co Ltd

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesMedexgen Co Ltd

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A